The American biotechnology company Moderna will submit an application for a marketing authorization in the European Union for its vaccine againstCovid for 12-17 years old: CEO Stéphane Bancel told the Journal du dimanche.
Considering that “by the summer all adults wishing to be vaccinated will have received a first dose”, Stéphane Bancel estimated that “it will then be necessary to target adolescents aged 12 to 17 very quickly”.
Today, only the Pfizer / BioNTech vaccine is authorized for 16-18 year olds in Europe; Pfizer has also applied for authorization for children between the ages of 12 and 16 and has already obtained it in the United States.
“The ideal would be to protect them by the end of August. If we do not vaccinate massively, the risk of a fourth wave cannot be ruled out,” added Stéphane Bancel, who has headed the biotech company since 2011.
.